Search - tctmd.com

Displaying 201 - 220 of 235

Sort: Relevancy | Date

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Conference News

APICE-OCT: EES, ZES Yield Low Rates of Uncovered Struts in ACS

November 08, 2011

Advertisement

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

SES Effective for Both Focal, Diffuse DES Restenosis

TCTMD’s Top 10 Most Popular News Stories From 2011

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Low Event Rates with EES Sustained at 2 Years

EES Compared Favorably with SES In Two Pivotal Trials

APICE-OCT: EES, ZES Yield Low Rates of Uncovered Struts in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content